US Stock MarketDetailed Quotes

PALI Palisade Bio

Watchlist
  • 2.5500
  • -0.2900-10.21%
Close Nov 6 16:00 ET
  • 2.4600
  • -0.0900-3.53%
Post 19:33 ET
3.39MMarket Cap-137P/E (TTM)

Palisade Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-59.12%-3.5M
9.81%-3.18M
16.67%-11.13M
16.94%-2.75M
12.43%-2.66M
32.34%-2.2M
6.32%-3.53M
9.56%-13.36M
-8.22%-3.31M
-10.71%-3.04M
Net income from continuing operations
-20.25%-4.08M
-50.73%-3.53M
13.74%-12.3M
20.13%-2.97M
9.90%-3.6M
-44.75%-3.39M
44.35%-2.34M
46.42%-14.26M
-446.69%-3.72M
-149.35%-3.99M
Operating gains losses
--5K
--4K
95.52%-59K
--0
--0
----
----
93.44%-1.32M
99.55%-23K
96.53%-385K
Depreciation and amortization
-50.00%1K
0.00%1K
33.33%4K
--0
--1K
--2K
0.00%1K
50.00%3K
--2K
--0
Other non cash items
352.50%101K
255.56%28K
386.96%198K
350.00%18K
417.39%238K
75.61%-40K
-140.00%-18K
-100.20%-69K
-91.67%4K
-68.71%46K
Change In working capital
-90.24%112K
115.53%196K
-68.00%400K
-93.62%22K
-52.50%493K
680.27%1.15M
-350.71%-1.26M
126.28%1.25M
46.81%345K
12,875.00%1.04M
-Change in receivables
----
--0
----
----
----
----
---250K
----
----
----
-Change in prepaid assets
-20.09%175K
-37.41%174K
-31.35%705K
-61.48%109K
-80.81%99K
691.89%219K
4.91%278K
188.76%1.03M
164.49%283K
1,620.00%516K
-Change in payables and accrued expense
-246.81%-599K
163.40%615K
-223.31%-492K
-0.33%-308K
-29.48%378K
78.17%408K
-1,544.07%-970K
116.66%399K
-22.80%-307K
4,566.67%536K
-Change in other current liabilities
-16.00%-29K
-12.00%-28K
30.46%-105K
-16.67%-28K
12.90%-27K
48.98%-25K
46.81%-25K
10.12%-151K
47.83%-24K
27.91%-31K
-Change in other working capital
----
-91.53%-565K
1,268.00%292K
-36.64%249K
----
----
32.80%-295K
97.77%-25K
-7.31%393K
165.38%17K
Cash from discontinued investing activities
Operating cash flow
-59.12%-3.5M
9.81%-3.18M
16.67%-11.13M
16.94%-2.75M
12.43%-2.66M
32.34%-2.2M
6.32%-3.53M
9.56%-13.36M
-8.22%-3.31M
-10.71%-3.04M
Investing cash flow
Cash flow from continuing investing activities
60.00%-4K
0
0
81.48%-10K
-10K
0
Net PPE purchase and sale
----
----
60.00%-4K
--0
--0
----
----
---10K
---10K
--0
Cash from discontinued investing activities
Investing cash flow
----
----
60.00%-4K
--0
--0
----
----
81.48%-10K
---10K
--0
Financing cash flow
Cash flow from continuing financing activities
-32.64%3.58M
-54.41%2.02M
-26.69%11.19M
-107.82%-134K
-86.96%1.57M
234.74%5.31M
5,203.45%4.44M
-38.00%15.26M
409.39%1.71M
165.02%12.05M
Net issuance payments of debt
--0
-79.55%-158K
50.51%-391K
62.03%-101K
42.42%-152K
71.10%-50K
-1.15%-88K
-331.69%-790K
45.04%-266K
60.24%-264K
Net common stock issuance
-26.61%4M
--0
-34.59%9.42M
--0
-86.23%1.74M
207.04%5.45M
--2.23M
176.46%14.4M
--0
142.39%12.63M
Proceeds from stock option exercised by employees
-77.08%11K
-7.64%2.5M
22.03%2.78M
-99.25%17K
--0
--48K
--2.71M
2,396.97%2.27M
--2.27M
--0
Net other financing activities
-212.95%-435K
22.28%-321K
1.59%-617K
82.99%-50K
95.27%-15K
---139K
---413K
-187.61%-627K
-320.00%-294K
---317K
Cash from discontinued financing activities
Financing cash flow
-32.64%3.58M
-54.41%2.02M
-26.69%11.19M
-107.82%-134K
-86.96%1.57M
234.74%5.31M
5,203.45%4.44M
-38.00%15.26M
409.39%1.71M
165.02%12.05M
Net cash flow
Beginning cash position
-15.17%11.3M
0.39%12.46M
17.95%12.41M
9.47%15.34M
228.19%16.43M
99.75%13.32M
17.95%12.41M
1,323.68%10.52M
-0.84%14.01M
-60.52%5.01M
Current changes in cash
-97.52%77K
-226.48%-1.16M
-97.40%49K
-79.78%-2.88M
-112.12%-1.09M
286.66%3.11M
123.73%914K
-80.70%1.89M
55.61%-1.6M
520.61%9.01M
End cash Position
-30.74%11.38M
-15.17%11.3M
0.39%12.46M
0.39%12.46M
9.47%15.34M
228.19%16.43M
99.75%13.32M
17.95%12.41M
17.95%12.41M
-0.84%14.01M
Free cash flow
-58.83%-3.5M
9.81%-3.18M
16.70%-11.14M
17.19%-2.75M
12.43%-2.66M
32.22%-2.2M
6.32%-3.53M
9.50%-13.37M
-8.54%-3.32M
-10.71%-3.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -59.12%-3.5M9.81%-3.18M16.67%-11.13M16.94%-2.75M12.43%-2.66M32.34%-2.2M6.32%-3.53M9.56%-13.36M-8.22%-3.31M-10.71%-3.04M
Net income from continuing operations -20.25%-4.08M-50.73%-3.53M13.74%-12.3M20.13%-2.97M9.90%-3.6M-44.75%-3.39M44.35%-2.34M46.42%-14.26M-446.69%-3.72M-149.35%-3.99M
Operating gains losses --5K--4K95.52%-59K--0--0--------93.44%-1.32M99.55%-23K96.53%-385K
Depreciation and amortization -50.00%1K0.00%1K33.33%4K--0--1K--2K0.00%1K50.00%3K--2K--0
Other non cash items 352.50%101K255.56%28K386.96%198K350.00%18K417.39%238K75.61%-40K-140.00%-18K-100.20%-69K-91.67%4K-68.71%46K
Change In working capital -90.24%112K115.53%196K-68.00%400K-93.62%22K-52.50%493K680.27%1.15M-350.71%-1.26M126.28%1.25M46.81%345K12,875.00%1.04M
-Change in receivables ------0-------------------250K------------
-Change in prepaid assets -20.09%175K-37.41%174K-31.35%705K-61.48%109K-80.81%99K691.89%219K4.91%278K188.76%1.03M164.49%283K1,620.00%516K
-Change in payables and accrued expense -246.81%-599K163.40%615K-223.31%-492K-0.33%-308K-29.48%378K78.17%408K-1,544.07%-970K116.66%399K-22.80%-307K4,566.67%536K
-Change in other current liabilities -16.00%-29K-12.00%-28K30.46%-105K-16.67%-28K12.90%-27K48.98%-25K46.81%-25K10.12%-151K47.83%-24K27.91%-31K
-Change in other working capital -----91.53%-565K1,268.00%292K-36.64%249K--------32.80%-295K97.77%-25K-7.31%393K165.38%17K
Cash from discontinued investing activities
Operating cash flow -59.12%-3.5M9.81%-3.18M16.67%-11.13M16.94%-2.75M12.43%-2.66M32.34%-2.2M6.32%-3.53M9.56%-13.36M-8.22%-3.31M-10.71%-3.04M
Investing cash flow
Cash flow from continuing investing activities 60.00%-4K0081.48%-10K-10K0
Net PPE purchase and sale --------60.00%-4K--0--0-----------10K---10K--0
Cash from discontinued investing activities
Investing cash flow --------60.00%-4K--0--0--------81.48%-10K---10K--0
Financing cash flow
Cash flow from continuing financing activities -32.64%3.58M-54.41%2.02M-26.69%11.19M-107.82%-134K-86.96%1.57M234.74%5.31M5,203.45%4.44M-38.00%15.26M409.39%1.71M165.02%12.05M
Net issuance payments of debt --0-79.55%-158K50.51%-391K62.03%-101K42.42%-152K71.10%-50K-1.15%-88K-331.69%-790K45.04%-266K60.24%-264K
Net common stock issuance -26.61%4M--0-34.59%9.42M--0-86.23%1.74M207.04%5.45M--2.23M176.46%14.4M--0142.39%12.63M
Proceeds from stock option exercised by employees -77.08%11K-7.64%2.5M22.03%2.78M-99.25%17K--0--48K--2.71M2,396.97%2.27M--2.27M--0
Net other financing activities -212.95%-435K22.28%-321K1.59%-617K82.99%-50K95.27%-15K---139K---413K-187.61%-627K-320.00%-294K---317K
Cash from discontinued financing activities
Financing cash flow -32.64%3.58M-54.41%2.02M-26.69%11.19M-107.82%-134K-86.96%1.57M234.74%5.31M5,203.45%4.44M-38.00%15.26M409.39%1.71M165.02%12.05M
Net cash flow
Beginning cash position -15.17%11.3M0.39%12.46M17.95%12.41M9.47%15.34M228.19%16.43M99.75%13.32M17.95%12.41M1,323.68%10.52M-0.84%14.01M-60.52%5.01M
Current changes in cash -97.52%77K-226.48%-1.16M-97.40%49K-79.78%-2.88M-112.12%-1.09M286.66%3.11M123.73%914K-80.70%1.89M55.61%-1.6M520.61%9.01M
End cash Position -30.74%11.38M-15.17%11.3M0.39%12.46M0.39%12.46M9.47%15.34M228.19%16.43M99.75%13.32M17.95%12.41M17.95%12.41M-0.84%14.01M
Free cash flow -58.83%-3.5M9.81%-3.18M16.70%-11.14M17.19%-2.75M12.43%-2.66M32.22%-2.2M6.32%-3.53M9.50%-13.37M-8.54%-3.32M-10.71%-3.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data